Literature DB >> 32180847

Diagnostic ability of contrast-enhanced computed tomography for metastatic cervical nodes in head and neck squamous cell carcinomas: significance of additional coronal reconstruction images.

Tomohiro Ando1, Hiroki Kato1, Masaya Kawaguchi1, Yukichi Tanahashi1, Mitsuhiro Aoki1, Bunya Kuze1, Masayuki Matsuo1.   

Abstract

PURPOSE: To evaluate the significance of additional coronal reconstruction images in the diagnostic ability of contrast-enhanced computed tomography (CECT) for metastatic cervical nodes in patients with head and neck squamous cell carcinomas (HNSCC).
MATERIAL AND METHODS: We retrospectively assessed 97 metastatic and 141 reactive histologically proven cervical nodes of 38 patients with HNSCC, who underwent CECT before neck dissection. Observer #1, an expert radiologist in head and neck imaging, and observer #2, a general radiologist, reviewed all CECT images. The observers first assessed the presence of nodal metastasis using axial CECT alone (A-CECT). Three days later, they reassessed its presence using combined axial and coronal CECT (A&C-CECT).
RESULTS: The sensitivity of A-CECT vs. A&C-CECT was 73.2% vs. 75.3% for observer #1 (p = 0.73) and 69.1% vs. 69.1% for observer #2 (p = 1.00), respectively. The specificity of A-CECT versus A&C-CECT was 92.2% vs. 97.2% for observer #1 (p < 0.05) and 92.9% vs. 95.7% for observer #2 (p = 0.22), respectively. The accuracy of A-CECT versus A&C-CECT was 84.5% vs. 88.2% for observer #1 (p < 0.05) and 83.2% vs. 85.3% for observer #2 (p = 0.30), respectively. The area under the curve (AUC) of A-CECT vs. A&C-CECT was 0.86 vs. 0.91 for observer #1 (p < 0.05) and 0.85 vs. 0.85 for observer #2 (p = 0.80), respectively.
CONCLUSIONS: The specificity, accuracy, and AUC increased with the use of coronal images during the assessment by the expert radiologist. The appropriate use of coronal images allowed proper configuration recognition and improved diagnostic ability.
Copyright © Polish Medical Society of Radiology 2020.

Entities:  

Keywords:  CT; coronal reconstruction images; head and neck squamous cell carcinomas; lymph node metastasis

Year:  2020        PMID: 32180847      PMCID: PMC7064011          DOI: 10.5114/pjr.2020.92668

Source DB:  PubMed          Journal:  Pol J Radiol        ISSN: 1733-134X


Introduction

The presence of metastatic cervical nodes is one of the most significant prognostic factors in patients with head and neck squamous cell carcinoma (HNSCC) because it influences the therapeutic strategy and clinical outcome [1-5].Palpation alone is often insufficient for the proper evaluation of cervical nodes, and radiographic imaging is useful for the assessment of anatomically deep cervical nodes, including retropharyngeal nodes [6,7]. Contrast-enhanced computed tomography (CECT) and magnetic resonance imaging (MRI) are widely used for the evaluation of nodal metastasis in HNSCC, and the size criterion of a maximum short-axis diameter of 10 mm, as proposed by van den Brekel et al. [8], has gained widespread acceptance. Central necrosis and indistinct margins indicating extranodal spread are reliable morphological features for the diagnosis of malignancy, particularly in small (< 10 mm) nodes [9,10]. Loss of fatty hilum is also a morphological feature suggestive of malignancy. However, although relatively high specificity of these morphological criteria has been reported, the sensitivity based on the size criteria on CT (71%) [8] and loss of fatty hilum on ultrasonography (30%) [11] is insufficient for the detection of nodal metastases. A meta-analysis of 16 studies regarding the diagnostic ability of CT and MRI in detecting metastatic cervical nodes in HNSCC found that the sensitivity was 64.2% and 67.4% and the specificity was 75.4% and 78.7% [12] for CT and MRI, respectively. In contrast, a meta-analysis of 13 studies with per-neck-level data found that the sensitivity was higher for 18F-fluorodeoxyglucose (18F-FDG)-PET/CT (84%) than CT, MRI, and CT/MRI (63%) [13]. However, because 18F-FDG-PET/CT is expensive and not easily available, CT and MRI are widely performed in patients with HNSCC. Therefore, it has been expected that CT and MRI show higher diagnostic performance for the detection of metastatic cervical nodes in HNSCC. With the widespread use of multi-detector computed tomography (MDCT), multiplanar reformation images are easily available in daily clinical practice. In the head and neck region, coronal reconstruction images are useful for identifying anatomical locations and evaluating morphological features. By adding the evaluation of cervical nodes using coronal images, the configuration recognition is often modified, in contrast to the evaluation using axial images alone. Although a few studies have compared the diagnostic ability between axial and coronal images [14-16], to the best of our knowledge, the utility of coronal images in addition to axial images for the diagnosis of metastatic cervical nodes in HNSCC has not been reported. Thus, the purpose of this study was to evaluate the significance of additional coronal reconstruction images in the diagnostic ability of CECT to identify metastatic cervical nodes in HNSCC.

Material and methods

Patients

The study was approved by the Research Ethics Committee of our Institutional Review Board and complied with the guidelines of the Health Insurance Portability and Accountability Act. The requirement for written, informed consent was waived due to the retrospective nature of this study. Between January 2015 and February 2018, the electronic medical records at our University Hospital were searched for the details of patients with HNSCC, who had undergone CECT within two months before neck dissection. After excluding patients who underwent chemotherapy or radiotherapy between CECT and surgery, 38 consecutive patients (29 males and 9 females; mean age, 66 years; age range, 32-88 years) were identified. The primary tumour sites were tongue (n = 9), gingiva (n = 9), hypopharynx (n = 6), larynx (n = 4), oropharynx (n = 3), skin (n = 3), palate (n = 2), maxillary sinus (n = 1), and nasal cavity (n = 1). The histological tumour grades of HNSCC were well differentiated in 24 patients, moderately differentiated in 10, and poorly differentiated in four. The clinical tumour stages according to the Union for International Cancer Control classification were stage I in two patients, stage II in seven, stage III in eight, and stage IV in 21. The patient characteristics are summarised in Table 1.
Table 1

Patient characteristics

Parameter
Number of patients, N38
Age (year)
 Mean66.1
 Range32–88
Gender, n
 Male29
 Female9
Primay tumor site, n
 Tongue9
 Gingiva9
 Hypopharynx6
 Larynx4
 Oropharynx3
 Skin3
 Palate2
 Maxillary sinus1
 Nasal cavity1
Histological tumor grade, n
 Well-differentiated24
 Moderately-differentiated10
 Poorly-differentiated4
UICC clinical stage, n
 I2
 II7
 III8
 IV21

UICC – Union for International Cancer Control

Patient characteristics UICC – Union for International Cancer Control

Computed tomography imaging

CT imaging was performed using a 64-slice CT system (Brilliance 64; Philips, Best, The Netherlands or Discovery 750 HD; GE Healthcare, Milwaukee, WI, USA). Axial and coronal CECT (A&C-CECT) images were obtained for all patients and reconstructed at a section thickness of 2.5-mm with no overlap. Single-phase CECT imaging was started 45 seconds after initiating an intravenous bolus injection of 100 ml of nonionic iodine contrast material (Optiray 240 [240 mg of iodine per ml]; Mallinckrodt Inc., Hazelwood, MO, USA) at an injection rate of 2 ml per second.

Image assessment

An expert radiologist with 19 years of post-training experience in head and neck imaging (observer #1) and a general radiologist with six years of post-training experience (observer #2) independently reviewed all CECT images. Both the observers were blinded to the patient data. They assessed cervical nodes on CECT images without observing the primary tumours to minimise the diagnostic bias for nodal metastasis. They first assessed the presence of nodal metastasis using axial CECT (A-CECT) alone. Three days later, they reassessed the presence of nodal metastasis using combined axial and coronal CECT (A&C-CECT) in a randomised fashion. The observers evaluated the presence or absence of nodal metastasis according to the following criteria. Lymph nodes were confirmed as positive for metastasis if they were ≥ 10 mm in maximum short-axis diameter, contained central necrosis, or had indistinct margins. If the above-mentioned positive findings were not observed, the loss of fatty hilum or spherical (round)-shaped configuration was considered an ancillary metastatic feature. A confidence level for the presence of metastatic nodes was assigned for each lymph node according to a four-point scale: 1, definitely absent; 2, probably absent; 3, probably present; and 4, definitely present.

Lymph node assessment

The location of cervical nodes was divided into seven different levels in the imaging-based nodal classification reported by Som et al. [17]. The surgeons who performed the neck dissections manually identified and localised the lymph nodes per neck level using the neck dissection specimens and recorded the maximum and minimum diameters of all nodal specimens. By comparing the location and size of the lymph nodes between nodal specimens and radiological assessment on CECT, it was possible to perform a topographical correlation for each lymph node. After the lymph node correlation, a pathologist reviewed all the nodal specimens and classified them into two categories: positive or negative for metastasis. Lymph nodes < 5 mm in maximum diameter on CECT were excluded from this study because they were more likely to be histologically diagnosed as negative for metastasis, and it was difficult to identify lymph nodes by pathological–radiological correlation.

Statistical analysis

All statistical analyses were performed using MedCalc 12.7.2 (MedCalc Software, Ostend, Belgium). The sensitivity, specificity, and accuracy for the detection of metastatic nodes were calculated, and McNemar’s test was performed to compare the results between A-CECT and A&C-CECT. Receiver operating characteristic curve analysis was used to determine the performance of the observers for each image set. Interobserver variability in the assessment of confidence level for the presence of metastatic nodes was analysed using kappa statistics.

Results

Among 120 dissected neck levels, a total of 238 histologically confirmed lymph nodes with a diameter ≥ 5 mm (97 nodes with metastasis and 141 nodes without metastasis) were found (Figures 1 and 2). The distribution of the 238 lymph nodes was as follows: level I (n = 52), II (n = 103), III (n = 49), IV (n = 23), V (n = 5), and VI (n = 6).
Figure 1

A 65-year-old man with tongue squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a spherical (round)-shaped left level III lymph node (arrow) with 8 mm in maximum short-axis diameter. Central necrosis is clearly demonstrated within the lymph node. B) Coronal contrast-enhanced computed tomography image also shows a spherical (round)-shaped lymph node (arrow) with central necrosis. Metastasis is pathologically confirmed within the lymph node

Figure 2

A 59-year-old man with oropharyngeal squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a flattened (oval)-shaped left level IB lymph node (arrow) with 6 mm in maximum short-axis diameter. Fatty hilum is clearly demonstrated (arrowhead). B) Coronal contrast-enhanced computed tomography image also shows a flattened (oval)-shaped lymph node (arrow) with fatty hilum (arrowhead). No evidence of metastasis is pathologically confirmed within the lymph node

A 65-year-old man with tongue squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a spherical (round)-shaped left level III lymph node (arrow) with 8 mm in maximum short-axis diameter. Central necrosis is clearly demonstrated within the lymph node. B) Coronal contrast-enhanced computed tomography image also shows a spherical (round)-shaped lymph node (arrow) with central necrosis. Metastasis is pathologically confirmed within the lymph node A 59-year-old man with oropharyngeal squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a flattened (oval)-shaped left level IB lymph node (arrow) with 6 mm in maximum short-axis diameter. Fatty hilum is clearly demonstrated (arrowhead). B) Coronal contrast-enhanced computed tomography image also shows a flattened (oval)-shaped lymph node (arrow) with fatty hilum (arrowhead). No evidence of metastasis is pathologically confirmed within the lymph node The sensitivity, specificity, accuracy, and area under curve (AUC) of A-CECT and A&C-CECT for the detection of metastatic lymph nodes are shown in Table 2. The sensitivity of A-CECT vs. A&C-CECT was 73.2% vs. 75.3% for observer #1 (p = 0.73) and 69.1% vs. 69.1% for observer #2 (p = 1.00), respectively. The specificity of A-CECT vs. A&C-CECT was 92.2% vs. 97.2% for observer #1 (p < 0.05) and 92.9% vs. 95.7% for observer #2 (p = 0.22), respectively. The accuracy of A-CECT vs. A&C-CECT was 84.5% vs. 88.2% for observer #1 (p < 0.05) and 83.2% vs. 85.3% for observer #2 (p = 0.30), respectively. The area under the curve (AUC) of A-CECT versus A&C-CECT was 0.86 vs. 0.91 for observer #1 (p < 0.05) and 0.85 vs. 0.85 for observer #2 (p = 0.80), respectively.
Table 2

Sensitivity, specificity, accuracy, and AUC for the detection of metastatic lymph nodes for each observer

Observerer #1Observerer #2
A-CECTA&C-CECTp valueA-CECTA&C-CECTp value
Sensitivity73.275.30.72769.169.11.000
Specificity92.297.20.039*92.995.70.219
Accuracy84.588.20.049**83.285.30.302
AUC0.860.910.011[]0.850.850.803

AUC – area under the curve, A-CECT – axial contrast-enhanced computed tomography, A&C-CECT – axial and coronal contrast-enhanced computed tomography

In sensitivity, specificity, and accuracy, data are percentages.

Specificity of A&C-CECT was greater than that of A-CECT (p < 0.05).

Accuracy of A&C-CECT was greater than that of A-CECT (p < 0.05).

AUC of A&C-CECT was greater than that of A-CECT (p < 0.05).

Sensitivity, specificity, accuracy, and AUC for the detection of metastatic lymph nodes for each observer AUC – area under the curve, A-CECT – axial contrast-enhanced computed tomography, A&C-CECT – axial and coronal contrast-enhanced computed tomography In sensitivity, specificity, and accuracy, data are percentages. Specificity of A&C-CECT was greater than that of A-CECT (p < 0.05). Accuracy of A&C-CECT was greater than that of A-CECT (p < 0.05). AUC of A&C-CECT was greater than that of A-CECT (p < 0.05). For the two observers, the κ values in the assessment of confidence level for the presence of metastatic nodes using A-CECT showed substantial agreement (0.73), and those using A&C-CECT also showed substantial agreement (0.71).

Discussion

In the present study, the specificity, accuracy, and AUC significantly improved by adding C-CECT to A-CECT during the assessment by the expert radiologist in head and neck imaging. In other words, the expert radiologist could obtain useful morphological information from C-CECT for the diagnosis of metastatic nodes. In contrast, although there was no significant difference in the sensitivity, specificity, accuracy, and AUC during the assessment by the general radiologist, the specificity slightly increased by adding C-CECT to A-CECT. The increase in specificity might help avoid overdiagnosis and overtreatment. Of the 141 histologically proven non-metastatic lymph nodes, the expert radiologist judged eight nodes as false positive using A-CECT and as true negative using A&C-CECT. In five of the eight lymph nodes, although spherical (round) shape on A-CECT led to a false positive diagnosis, flattened (oval) shape on C-CECT led to a true negative diagnosis (Figure 3). In the three remaining lymph nodes, although fatty hilum could not be detected on A-CECT, it could be detected on C-CECT (Figure 4).
Figure 3

A 59-year-old man with gingival squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a spherical (round)-shaped right level IIA lymph node (arrow) with 9 mm in maximum short-axis diameter. The reviewers judged a score of 3 (probably present) because of the spherical configuration. B) Coronal contrast-enhanced computed tomography image reveals a flattened (oval)-shaped lymph node (arrow), and the maximum diameter of this lymph node is 25 mm. No evidence of metastasis is pathologically confirmed within the lymph node. An expert radiologist can accurately modify the judgement to a score of 2 (probably absent)

Figure 4

A 53-year-old woman with gingival squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a flattened (oval)-shaped right level IIA lymph node (arrow) with 9 mm in maximum short-axis diameter. The reviewers judged a score of 3 (probably present) because of the loss of fatty hilum. B) Coronal contrast-enhanced computed tomography image reveals a flattened (oval)-shaped lymph node (arrow) with the fatty hilum (arrowhead) at the lower end of lymph node. No evidence of metastasis is pathologically confirmed within the lymph node. An expert radiologist can accurately modify the judgement to a score of 2 (probably absent)

A 59-year-old man with gingival squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a spherical (round)-shaped right level IIA lymph node (arrow) with 9 mm in maximum short-axis diameter. The reviewers judged a score of 3 (probably present) because of the spherical configuration. B) Coronal contrast-enhanced computed tomography image reveals a flattened (oval)-shaped lymph node (arrow), and the maximum diameter of this lymph node is 25 mm. No evidence of metastasis is pathologically confirmed within the lymph node. An expert radiologist can accurately modify the judgement to a score of 2 (probably absent) A 53-year-old woman with gingival squamous cell carcinoma. A) Axial contrast-enhanced computed tomography image shows a flattened (oval)-shaped right level IIA lymph node (arrow) with 9 mm in maximum short-axis diameter. The reviewers judged a score of 3 (probably present) because of the loss of fatty hilum. B) Coronal contrast-enhanced computed tomography image reveals a flattened (oval)-shaped lymph node (arrow) with the fatty hilum (arrowhead) at the lower end of lymph node. No evidence of metastasis is pathologically confirmed within the lymph node. An expert radiologist can accurately modify the judgement to a score of 2 (probably absent) The size of the lymph nodes is usually evaluated using both short- and long-axis diameters. Although the larger the size of the lymph node, the greater the risk of malignancy, benign reactive lymphadenitis or reactive hyperplasia of the lymph node can also result in nodes as large as malignant ones. For that reason, the short-axis diameter, which is measured perpendicular to the longest diameter of the lymph node, is recommended for the assessment of nodal metastasis [8]. Short-axis/long-axis (SL) ratio has also been widely used to differentiate reactive nodes from metastatic ones as a size criterion [18,19]. Specifically, benign lymph nodes tend to have an SL ratio of < 0.5, whereas metastatic lymph nodes tend to have an SL ratio of > 0.5 on both CT [18] and ultrasonography [19]. Although this size criterion is relatively simple and easy to follow, evaluation using axial CT images alone may sometimes fail to measure the true short- and long-axis diameters. If elliptical lymph nodes occur along the axis of the body, they might be regarded as malignant due to the spherical (round) configuration assessed by axial CT images alone (Figure 3). Thus, to measure the true short- and long-axis diameters, it is necessary to evaluate coronal or sagittal reconstruction CT images in addition to axial CT images. The presence of fatty hilum is also one of the morphological features of benign lymph nodes, whereas its loss is an ancillary feature of malignancy [11,19,20]. Although the diagnostic criterion of the presence or absence of fatty hilum tends to have higher specificity, the sensitivity tends to be relatively low [11]. In some cases in our study, the detection of fatty hilum was improved by adding the assessment of C-CECT (Figure 4). The addition of C-CECT may also contribute to the prevention of misdiagnosis regarding the partial-volume effect of fatty hilum as central necrosis. However, if the intranodal cancer nest is small, fatty hilum may also be found in metastatic nodes [21]. In other words, although the addition of C-CECT may improve the diagnostic ability, it is still difficult to identify micrometastases within lymph nodes. The present study has several limitations. First, the sample size was small because the study was conducted at a single institution. Second, due to the retrospective nature of this study, two different CT scanners were used. However, we believe that the results would not have differed considerably if we had obtained images using the same CT scanner. Third, in the present study, lymph nodes < 5 mm in maximum diameter were excluded because of the low probability of nodal metastasis and the difficulty in identification by pathological–radiological correlation. However, micrometastases might be present within these small lymph nodes.

Conclusions

Proper configuration recognition of cervical nodes using additional coronal reconstruction images improved the specificity, accuracy, and AUC for the detection of metastatic nodes in patients with HNSCC. The increase in specificity facilitated the accurate exclusion of nodal metastasis and might help avoid overdiagnosis and overtreatment.

Conflict of interest

The authors report no conflict of interest.
  21 in total

1.  Imaging-based nodal classification for evaluation of neck metastatic adenopathy.

Authors:  P M Som; H D Curtin; A A Mancuso
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

Review 2.  Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease.

Authors:  O Sakai; H D Curtin; L V Romo; P M Som
Journal:  Radiol Clin North Am       Date:  2000-09       Impact factor: 2.303

Review 3.  Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis.

Authors:  Lian-Ming Wu; Jian-Rong Xu; Man-Ju Liu; Xiao-Fei Zhang; Jia Hua; Jasmine Zheng; Jia-Ni Hu
Journal:  Acad Radiol       Date:  2011-12-06       Impact factor: 3.173

4.  Comparison of CT and MR imaging in staging of neck metastases.

Authors:  H D Curtin; H Ishwaran; A A Mancuso; R W Dalley; D J Caudry; B J McNeil
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

5.  False-positive computed tomography scan mimicking metastasis due to fatty hilum in a cervical lymph node.

Authors:  M Elson; M Rothman; R A Ord
Journal:  J Oral Maxillofac Surg       Date:  1994-12       Impact factor: 1.895

6.  Outcome of treatment for advanced cervical metastatic squamous cell carcinoma.

Authors:  Jonathan Clark; Wei Li; Graham Smith; Kerwin Shannon; Anthony Clifford; Ed McNeil; Kan Gao; Michael Jackson; Mo Mo Tin; Christopher O'Brien
Journal:  Head Neck       Date:  2005-02       Impact factor: 3.147

Review 7.  (18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis.

Authors:  Rong Sun; Xinye Tang; Yang Yang; Cheng Zhang
Journal:  Oral Oncol       Date:  2015-01-22       Impact factor: 5.337

8.  Metastatic retropharyngeal lymph nodes: comparison of CT and MR imaging for diagnostic accuracy.

Authors:  Hiroki Kato; Masayuki Kanematsu; Haruo Watanabe; Keisuke Mizuta; Mitsuhiro Aoki
Journal:  Eur J Radiol       Date:  2014-03-29       Impact factor: 3.528

9.  Can axial-based nodal size criteria be used in other imaging planes to accurately determine "enlarged" head and neck lymph nodes?

Authors:  Eric S Bartlett; Thomas D Walters; Eugene Yu
Journal:  ISRN Otolaryngol       Date:  2013-07-24

10.  Unidimensional Measurement May Evaluate Target Lymph Nodal Response After Induction Chemotherapy for Nasopharyngeal Carcinoma.

Authors:  Chuanben Chen; Mingwei Zhang; Yuanji Xu; Qiuyuan Yue; Penggang Bai; Lin Zhou; Youping Xiao; Dechun Zheng; Kongqi Lin; Sufang Qiu; Yunbin Chen; Jianji Pan
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.